Cargando…

Less Invasive Surfactant Administration: A Review of Current Evidence of Clinical Outcomes With Beractant

Evidence supporting clinical recommendations or approval for less invasive surfactant administration (LISA) has primarily examined heterogeneous or small-volume (e.g., 1.25-2.5 mL/kg) animal-derived surfactant regimens. To address the evidence gap for larger-volume (e.g., 4-5 mL/kg) animal-derived s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sanchez Luna, Manuel, Unnebrink, Kristina, Martinez-Tristani, Marisol, Ramos Navarro, Cristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2022
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9651081/ https://www.ncbi.nlm.nih.gov/pubmed/36381708 http://dx.doi.org/10.7759/cureus.30223

Ejemplares similares

Beractant and poractant alfa in premature neonates with respiratory distress syndrome: a systematic review of real-world evidence studies and randomized controlled trials
por: Sánchez Luna, Manuel, et al.
Publicado: (2020)

Less invasive beractant administration in preterm infants: a pilot study
por: Ramos-Navarro, Cristina, et al.
Publicado: (2016)

Comparison of mortality and short-term outcomes between classic, intubation-surfactant-extubation, and less invasive surfactant administration methods of surfactant replacement therapy
por: Kim, Seung Yeon, et al.
Publicado: (2023)

Less invasive surfactant administration and complications of preterm birth
por: Härtel, Christoph, et al.
Publicado: (2018)

Less invasive surfactant administration (LISA): chances and limitations
por: Herting, Egbert, et al.
Publicado: (2019)

Less invasive surfactant administration: best practices and unanswered questions
por: Herting, Egbert, et al.
Publicado: (2020)

Less Invasive Surfactant Administration in Very Prematurely Born Infants
por: Shetty, Sandeep, et al.
Publicado: (2021)

Minimally Invasive Surfactant Administration for the Treatment of Neonatal Respiratory Distress Syndrome: A Multicenter Randomized Study in China
por: Han, Tongyan, et al.
Publicado: (2020)

Clinical evaluation of an application aid for less-invasive surfactant administration (LISA)
por: Maiwald, Christian Achim, et al.
Publicado: (2021)

Late Administration of Surfactant May Increase the Risk of Patent Ductus Arteriosus
por: Canpolat, Fuat Emre, et al.
Publicado: (2020)

Lung Beractant Increases Free Cytosolic Levels of Ca(2+) in Human Lung Fibroblasts
por: Guzmán-Silva, Alejandro, et al.
Publicado: (2015)

Quality assessment and response to less invasive surfactant administration (LISA) without sedation
por: de Kort, Ellen, et al.
Publicado: (2019)

Improved Less Invasive Surfactant Administration Success in Preterm Infants after Procedure Standardization
por: Liebers, Björn, et al.
Publicado: (2021)

New techniques, new challenges—The dilemma of pain management for less invasive surfactant administration?
por: Balakrishnan, Ashanti, et al.
Publicado: (2020)

Curriculum and assessment tool for less invasive surfactant administration: an international Delphi consensus study
por: Breindahl, Niklas, et al.
Publicado: (2023)

The Efficacy of Surfactant Replacement Therapy in the Growth-Restricted Preterm Infant: What is the Evidence?
por: Malhotra, Atul, et al.
Publicado: (2014)

Effect of Nasal Continuous Airway Pressure With and Without Surfactant Administration for the Treatment of Respiratory Distress Syndrome in Preterm Neonates
por: Malibary, Husam, et al.
Publicado: (2023)

Implementation of less invasive surfactant administration in clinical practice—Experience of a mid-sized country
por: Szczapa, Tomasz, et al.
Publicado: (2020)

Should less invasive surfactant administration (LISA) become routine practice in US neonatal units?
por: Kakkilaya, Venkatakrishna, et al.
Publicado: (2022)

Association of Administration of Surfactant Using Less Invasive Methods With Outcomes in Extremely Preterm Infants Less Than 27 Weeks of Gestation
por: Härtel, Christoph, et al.
Publicado: (2022)

Surfactant Administration Through Laryngeal or Supraglottic Airways (SALSA): A Viable Method for Low-Income and Middle-Income Countries
por: Zapata, Henry A., et al.
Publicado: (2022)

Structural and haemodynamic evaluation of less invasive surfactant administration during nasal intermittent positive pressure ventilation in surfactant-deficient newborn piglets
por: Mielgo, Victoria, et al.
Publicado: (2023)

Mortality in preterm infants with respiratory distress syndrome treated with poractant alfa, calfactant or beractant: a retrospective study
por: Ramanathan, R, et al.
Publicado: (2013)

Lung ultrasound to guide the administration of exogenous pulmonary surfactant in respiratory distress syndrome of newborn infants: A retrospective investigation study
por: Liu, Jing, et al.
Publicado: (2022)

Less Invasive Surfactant Administration Reduces the Need for Mechanical Ventilation in Preterm Infants: A Meta-Analysis
por: Lau, Christine S. M., et al.
Publicado: (2017)

Microbiological analyses of nasally guided catheters after less invasive surfactant administration – a pilot study
por: Maiwald, Christian A., et al.
Publicado: (2020)

Introducing Less-Invasive Surfactant Administration into a Level IV NICU: A Quality Improvement Initiative
por: Conlon, Steven M., et al.
Publicado: (2021)

Assessment of Comfort during Less Invasive Surfactant Administration in Very Preterm Infants: A Multicenter Study
por: Pichler, Karin, et al.
Publicado: (2023)

FiO(2) Before Surfactant, but Not Time to Surfactant, Affects Outcomes in Infants With Respiratory Distress Syndrome
por: Kruczek, Piotr, et al.
Publicado: (2021)

A pilot study of less invasive surfactant administration in very preterm infants in a Chinese tertiary center
por: Bao, Yingying, et al.
Publicado: (2015)

Airway injury and pneumomediastinum associated with less invasive surfactant administration in a premature neonate: a case report
por: Altamimi, Talal, et al.
Publicado: (2021)

Less invasive surfactant administration is associated with a higher need for nonpharmacological pain‐relieving interventions compared to the intubation‐surfactant extubation technique in preterm infants
por: Höck, Michaela, et al.
Publicado: (2020)

Should Minimally Invasive Surfactant Therapy be a Must in Neonatal Intensive Care Units? Pilot Report of Initial Cases in Dubai
por: Gengaimuthu, Karthikeyan
Publicado: (2018)

Endotracheal Surfactant Combined With Budesonide for Neonatal ARDS
por: Deliloglu, Burak, et al.
Publicado: (2020)

A randomised controlled trial in preterm infants comparing prophylactic with selective “less invasive surfactant administration” (pro.LISA)
por: Göpel, Wolfgang, et al.
Publicado: (2023)

Five‐country manikin study found that neonatologists preferred using the LISAcath rather than the Angiocath for less invasive surfactant administration
por: Fabbri, Laura, et al.
Publicado: (2018)

Introduction of less invasive surfactant administration (LISA), impact on diagnostic and therapeutic procedures in early life: a historical cohort study
por: Bugter, I. A. L., et al.
Publicado: (2020)

CSF Surfactant Protein Changes in Preterm Infants After Intraventricular Hemorrhage
por: Krause, Matthias, et al.
Publicado: (2020)

A multicenter, randomized controlled, non-inferiority trial, comparing nasal continuous positive airway pressure with nasal intermittent positive pressure ventilation as primary support before minimally invasive surfactant administration for preterm infants with respiratory distress syndrome (the NIV-MISA-RDS trial): Study protocol
por: Zhang, Hui, et al.
Publicado: (2022)

Surfactant Therapy for Respiratory Distress Syndrome in High- and Ultra-High-Altitude Settings
por: Duan, Xudong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0ke4tp0q6d8jaq8vaml8ohs195